Determinants of plasma calretinin in patients with malignant pleural mesothelioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Determinants of plasma calretinin in patients with malignant pleural mesothelioma ; volume:13 ; number:1 ; day:29 ; month:7 ; year:2020 ; pages:1-6 ; date:12.2020
BMC Research Notes / Biomed Central; 13, Heft 1 (29.7.2020), 1-6, 12.2020
- Creator
-
Lehnert, Martin
Weber, Daniel G.
Taeger, Dirk
Raiko, Irina
Kollmeier, Jens
Stephan-Falkenau, Susann
Brüning, Thomas
Johnen, Georg
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-020-05187-y
- URN
-
urn:nbn:de:101:1-2020092522034582904266
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lehnert, Martin
- Weber, Daniel G.
- Taeger, Dirk
- Raiko, Irina
- Kollmeier, Jens
- Stephan-Falkenau, Susann
- Brüning, Thomas
- Johnen, Georg
- SpringerLink (Online service)
Other Objects (12)
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma : a pilot study
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Assessment of miR-103a-3p in leukocytes : no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases
Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis
Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma : a pilot study
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Assessment of miR-103a-3p in leukocytes : no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases
Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis
Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
Untersuchungen zur Charakterisierung von LDL- und HDL-Rezeptoren
Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma : a pilot study
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
Assessment of miR-103a-3p in leukocytes : no diagnostic benefit in combination with the blood-based biomarkers mesothelin and calretinin for malignant pleural mesothelioma diagnosis
Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases
Combination of MiR-103a-3p and mesothelin improves the biomarker performance of malignant mesothelioma diagnosis
Circulating miR-132-3p as a candidate diagnostic biomarker for malignant mesothelioma